NEOADJUVANT PUBLICATIONS & ABSTRACTS

Neoadjuvant data


Neoadjuvant publications

Evidence / Neoadjuvant

MammaPrint and BluePrint Predict Pathological Response to Neoadjuvant Chemotherapy in Patients With HR+HER2- Early-Stage Breast Cancer Enrolled in FLEX

Title: MammaPrint® and BluePrint® Predict Pathological Response to Neoadjuvant Chemotherapy in Patients With HR+HER2- Early-Stage Breast Cancer Enrolled in FLEX  Background: For patients with hormone receptor-positive (HR+), HER2-negative early-stage breast cancer (EBC), pathological Complete Response (pCR) rates to neoadjuvant chemotherapy (NCT) are low. However, NBRST and I-SPY2 trials report Read More

Neoadjuvant Chemotherapy for T3 tumors in the Era of Precision Medicine- Biology is Still King

Title: Neoadjuvant Chemotherapy for T3 tumors in the Era of Precision Medicine- Biology is Still King Authors: Rakhshanda Rahman, Christin Collins*, Laura Lee, Alfredo Santillan, Mehran Habibi, Peter Blumencranz, Charlie Cox, James Pellicane, Peter Beitsch, Pat Whitworth, Harshini Ramaswamy, Nicole Stivers, Andrea Menicucci, William Audeh, Joyce O'Shaughnessy *Presenting Author Read More

Hormone Receptor Positive HER2-negative/MammaPrint High-2 Breast Cancers Closely Resemble Triple Negative Breast Cancers

Title: Hormone Receptor Positive HER2-negative/MammaPrint High-2 Breast Cancers Closely Resemble Triple Negative Breast Cancers Publication: Clin Cancer Res. 2024 Nov 19. doi: 10.1158/1078-0432.CCR-24-1553. Authors: Alejandro Rios-Hoyo, Kaitlyn Xiong, Jiawei Dai, Christina Yau, Michal Marczyk, Rolando Garcia-Milian, Denise M Wolf, Laura A Huppert, Rita Nanda, Gillian L Hirst, Erin F Read More